Istanbul

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Amyloidosis2 trials
• Dermatomyositis and polymyositis (myositis)1 trial
• High blood pressure1 trial

Phase

• Phase 34 trials

Status

• Recruiting3 trials
• Completed1 trial

Lead sponsor

• Alnylam Pharmaceuticals3 trials
• Priovant Therapeutics, Inc.1 trial

Running trials

• Recruiting

  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  NCT07223203· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT07052903· Phase 3· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis2 recruiting
• High blood pressure1 recruiting

Closed trials

• Completed

  A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

  NCT05437263· Phase 3· Priovant Therapeutics, Inc.· Source